CARCINOSTATIC AGENT CONTAINING PTEROSIN

摘要

PURPOSE:To obtain a carcinostatic agent for human administration, having low toxicity, containing a compound having pterosin skeleton extracted from a ferm as an active ingredient. CONSTITUTION:A carcinostatic agent containing a pterosin compound (especially preferably pterosin S3-O-beta-D-glucoside shown by formula II or pterosin S shown by formula III) shown by formula I (R1 is methyl or hydroxymethyl; R2 is hydroxyl saccharide residue). The carcinostatic agent can be orally or parenterally administered. A does in parenteral administration is 0.01-10mg/kg.day.